The LAI Challenge seeks innovative solutions in the field of sustained-release injectable drug delivery technologies...
3 min
24 Nov, 2022
ROVI updates its strategy in a meeting with shareholders, investors and analysts
1 min
23 Nov, 2022
ROVI reports operating revenue growth of 24% and EBITDA growth of 25%
3 min
04 Nov, 2022
This new facility will double the production capacity of low molecular weight heparins.
4 min
24 Oct, 2022
ROVI, Càrniques Celrà and Grupo Costa announce the construction of a facility at the Industrial Logistics Platform in...
3 min
04 Oct, 2022
ROVI has obtained the best ESG score from among the 458 companies evaluated in its pharmaceutical subindustry category.
2 min
01 Aug, 2022
ROVI reports operating revenue growth of 31% and net profit growth of 58%
3 min
27 Jul, 2022
EIB and ROVI are signing a EUR 50 million loan agreement in Madrid for research, development and innovation.
4 min
19 Jul, 2022
ROVI reports operating revenue growth of 57% and net profit growth of 123%
2 min
11 May, 2022